Search

everythinglearnresearchcommunity

for

Search:↓

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

The scalp microbiome is more diverse and may be more important in hair loss than the gut microbiome.

Older, overweight women with children and a family history of hair loss are more likely to experience female pattern hair loss.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Certain gene variations might be linked to severe acne in women but not in men.

Androgen levels do not determine the type of PCOS symptoms in young females.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Indian women with PCOS may need different ultrasound criteria for diagnosis than current standards.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Exercising women with irregular periods have lower thyroid hormone levels and less body fat.

Lower ghrelin levels and certain gene variations may increase acne risk.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Gastrointestinal issues are important risk factors for sebaceous gland diseases in Han adolescents.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

The woman had a rare adrenal tumor removed, and she recovered well with no signs of the tumor returning.

Ovarian stromal hyperplasia can cause high testosterone in postmenopausal women and is treated by removing the ovaries.

Women with PCOS have higher body fat and skinfold thickness, especially in the H-O-POM phenotype.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

Early hair loss may indicate a higher risk of diabetes in young and middle-aged adults.

Women with PCOS have distinct clinical and hormonal differences, requiring thorough evaluation for proper diagnosis and management.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).